Union Korea Pharm Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 836.31 million compared to KRW 572.73 million a year ago. Net loss was KRW 2,084.19 million compared to KRW 2,560.56 million a year ago.

Basic loss per share from continuing operations was KRW 289 compared to KRW 341 a year ago. Basic loss per share was KRW 289 compared to KRW 341 a year ago.